# 2026-14704: DEA Reviews Bulk Schedule I Drug Manufacturing Request

2026-14704, Bulk Manufacturer of Controlled Substances Application: Cerilliant Corporation, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2026-07-22, effective Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before September 21, 2026. Such persons may also file a written request for a hearing on the application on or before September 21, 2026. (as of 2026-07-29).

- Canonical: https://policyrisk.com/federal-register/2026-14704
- As of: 2026-07-29
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-14704
- Title: Bulk Manufacturer of Controlled Substances Application: Cerilliant Corporation
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 91 FR 46169
- Published: 2026-07-22
- Effective: Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before September 21, 2026. Such persons may also file a written request for a hearing on the application on or before September 21, 2026.
- Comments close: 2026-09-21
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-07-29

## In one line

DEA Reviews Bulk Schedule I Drug Manufacturing Request

## Summary

Cerilliant Corporation wants to become an official bulk maker of some powerful controlled substances, mostly in Schedule I. This affects anyone involved in drug manufacturing or regulation, with a chance to comment or request a hearing by September 21, 2026. No direct costs are mentioned, but the decision could impact how these substances are produced and controlled.

## Abstract

Cerilliant Corporation has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to supplementary information listed below for further drug information.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-20749](https://policyrisk.com/federal-register/2026-20749): Vladimir Romaniv, P.A.; Decision and Order, 2026-10-09
- [2026-20750](https://policyrisk.com/federal-register/2026-20750): L Krenk DBA Maui Clinic Pharmacy; Decision and Order, 2026-10-09

## Sources
- [2026-14704 on federalregister.gov](https://www.federalregister.gov/documents/2026/07/22/2026-14704/bulk-manufacturer-of-controlled-substances-application-cerilliant-corporation)
- [2026-14704 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-07-22/pdf/2026-14704.pdf)

## Related
- [Previous: 2026-14703, Personnel Demonstration Project at the United States Army Communications-Electr…](https://policyrisk.com/federal-register/2026-14703)
- [Next: 2026-14705, Agency Information Collection Activities: Proposed Collection: Public Comment R…](https://policyrisk.com/federal-register/2026-14705)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-14704 (as of 2026-07-29).